Trial of Erlotinib, Gemcitabine and Cisplatin in Metastatic Pancreatic Cancer

NCT00922896 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Pancreatic Cancer

Interventions

DRUG: Gemcitabine, Cisplatin, Erlotinib (Tarceva)

Sponsor

Gyeongsang National University Hospital

Collaborators

[object Object]
[object Object]